Global IT Outage Update

Every day we care for and treat hundreds of patients from Greater Manchester and beyond who come through our doors.


Today's global IT outage affected many organisations including ours but to put it into context, this outage affected less than a third of our patients.


Our staff worked tirelessly to deliver as many chemotherapy and immunotherapy treatments as possible and continue to finalise plans for those we were unable to see today due to issues affecting our supplier.


Thank you for being understanding and bearing with us. Unless our teams contact you, please attend for your appointment as planned.


We continue to work with our supplier to resolve this issue and prioritise our most clinically urgent patients. We apologise for any delays that have occurred as a result of this.


Any further updates will be published on our website and social media channels (Facebook and X/Twitter)

Skip to Content


We partner and collaborate with health, academic, scientific and industry organisations.

Our partnerships and collaborations help us deliver high quality clinical trials, attract top researchers and develop practice-changing cancer research.


The Christie has a number of key health and research partners.


The Christie collaborate in national health and research networks and initiatives.


The Christie collaborates on a range of regional health and research initiatives, including the following:


International partners help The Christie’s Research and Innovation division deliver high-quality clinical trials, attract top researchers and develop practice-changing cancer research.

  • Since July 2021, The Christie has been part of a global health partnership, the Kenya UK Healthcare Alliance. Through this alliance, researchers from The Christie and The University of Manchester are collaborating with Kenyan researchers in an NIHR-funded ‘Global Health Research Group Programme’ investigating early detection of oesophageal cancer.


The Christie works with around 250 national and international pharmaceutical industry organisations. We also work with clinical research organisations (CROs), pharmaceutical product development (PPD) and collaborate with industry through NIHR and academically-funded research programmes.

  • slider image

Last updated: January 2024